Skip to main content
All lobbying filings

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION filed a Q4 report for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION on January 14, 2026, reporting $245,484 in lobbying income.

Lobbying for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

All filings by CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Everything CONSUMER HEALTHCARE PRODUCTS ASSOCIATION has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 14, 2026
Income
$245,484
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.

H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

- Pharmaceutical Tariffs

 Bills named in this filing 13
  • S. 2292
    Over-the-Counter Monograph Drug User Fee Amendments
  • H.R. 4273
    Over-the-Counter Monograph Drug User Fee Amendments
  • S. 355
    FDA Modernization Act 3.0
  • H.R. 2821
    FDA Modernization Act 3.0
  • H.R. 3686
    SAFE Sunscreen Standards Act
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • S. 2491
    SAFE Sunscreen Standards Act
  • S. 2529
    A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription …
  • H.R. 6868
    ACCESS Through OTC Innovation Act
  • S. 3122
    Better FDA Act of 2025
  • H.R. 4958
    GRAS Act
  • H.R. 1219
    Oral Health Products Inclusion Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem